Evaluation of pharmaceutical clinical interventions in the ICU of a public hospital of Santa Catarina
DOI:
https://doi.org/10.30968/rbfhss.2018.093.005Abstract
Objectives: This study aimed to analyze the profile of pharmaceutical clinical interventions performed concurrently with the medical prescription evaluation service. Methods: This is a cross-sectional, prospective and observational study conducted at the General Intensive Care Unit of a public hospital in Santa Catarina, Brazil, with 8 beds in full occupation. The study included 54 patients hospitalized from February to July 2017. Included in the study were medical prescriptions and pharmaceutical interventions recorded in the electronic medical record of patients of both genders of any race, origin, age and pathology. Medical prescriptions and pharmaceutical interventions that did not belong to the hospitalization unit studied and the study period were excluded from the study. Results: A total of 499 medical prescriptions belonging to 54 patients (48%), male patients (68%), hypertensive patients (27%), diabetic patients (22%) and polytrauma patients (13%) were analyzed. Of the prescriptions analyzed, 91.1% had a need for pharmaceutical intervention with a total of 64.2% acceptance. The main drug-related problems were drug interaction (40%), potential adverse effect (28%) and need for dose adjustment (13%). The classes of drugs that most needed intervention were analgesics (23%), cardiovascular (14%) and antimicrobials (13%). Conclusions: In assessing clinical pharmaceutical interventions as a benefit in addition to critical care in the Intensive Care Unit we emphasize the percentage of acceptance of pharmaceutical interventions (64%), mostly those involving increased risk for adverse effects and drug interactions, thus contributing to the prevention of complications.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
